Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.

about

Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.

Item

http://www.wikidata.org/entity/Q55083994

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@en

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@nl

type

Item

label

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@en

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@nl

prefLabel

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@en

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@nl

P1476

Erythrocyte-bound C4d in combi ...... tus for the monitoring of SLE.

@en

P2093

Chaim Putterman

http://www.w3.org/2001/XMLSchema#string

Jill Buyon

http://www.w3.org/2001/XMLSchema#string

Joan T Merrill

http://www.w3.org/2001/XMLSchema#string

John Conklin

http://www.w3.org/2001/XMLSchema#string

Kenneth Kalunian

http://www.w3.org/2001/XMLSchema#string

Richard A Furie

http://www.w3.org/2001/XMLSchema#string

Rosalind Ramsey-Goldman

http://www.w3.org/2001/XMLSchema#string

Thierry Dervieux

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus

Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.

Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements

A quantitative lateral flow assay to detect complement activation in blood

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus

Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosus.

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Combined oral contraceptives in women with systemic lupus erythematosus.

Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease

P304

e000263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/LUPUS-2018-000263

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A. Petri

P577

2018-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29868177

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

5976122

http://www.w3.org/2001/XMLSchema#string